Literature DB >> 2385818

Management of portal venous thrombosis in hepatic transplant recipients.

P Neuhaus1, W O Bechstein, G Blumhardt, R Steffen.   

Abstract

Portal venous thrombosis in hepatic transplant candidates is considered a relative contraindication to transplantation. In addition to thrombectomy, which is often technically impossible, donor portal venous arterialization or extra-anatomic venous bypass have been described. Two patients who underwent portal venous resection and subsequent anatomic reconstruction are presented herein. In the first patient, a graft with donor common iliac vein was interposed, and in the second, the donor portal vein was long enough to be anastomosed to the mesentericosplenic venous confluens. One patient is well 12 months after transplantation with patent portal vein and the other died of fungal sepsis after rejection treatment (the portal vein being open and unobstructed at autopsy).

Entities:  

Mesh:

Year:  1990        PMID: 2385818

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  3 in total

1.  A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation.

Authors:  T J Gayowski; I R Marino; H R Doyle; L Echeverri; L Mieles; S Todo; M Wagener; N Singh; V L Yu; J J Fung; T E Starzl
Journal:  J Surg Res       Date:  1996-02-01       Impact factor: 2.192

2.  Use of Left Gastric Vein as an Alternative for Portal Flow Reconstruction in Liver Transplantation.

Authors:  Uirá Fernandes Teixeira; Mayara Christ Machry; Marcos Bertozzi Goldoni; Cristine Kruse; João Alfredo Diedrich; Pablo Duarte Rodrigues; Caroline Becker Giacomazzi; Estéfano Aurélio Negri; Matheus Koop; Carlos Gustavo Spode Gomes; José Artur Sampaio; Paulo Roberto Ott Fontes; Fábio Luiz Waechter
Journal:  Case Rep Surg       Date:  2016-08-09

3.  A modified kidney-sparing portal vein arterialization model of heterotopic auxiliary liver transplantation increases liver IL-6, TNF-α, and HGF levels and enhances liver regeneration: an animal model.

Authors:  Jun Li; Jianjun Ren; JunJing Zhang; Xingkai Meng
Journal:  BMC Surg       Date:  2022-07-21       Impact factor: 2.030

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.